Thursday, March 18, 2010

What is packaging design? (Essential design handbook)

What is Packaging Design? (Essential Design Handbook)


This is a highly visual, compact-format sourcebook, packed with top international packaging designers' contemporary work, accompanied by essays on the surrounding issues.


                                                                   DOWNLOAD

Friday, February 19, 2010

INDIAN PHARMACOPOEIA

Indian Pharmacopoeia (2007)



The latest edition of the Indian Pharmacopoeia was published in 1996. It was updated by additions and amendments introduced through addendum 2000. Under the Drugs and Cosmetics Act, 1940, the Indian Pharmacopoeia is the legally recognised book of standards for the quality of drug substances and their preparations included therein. In view of the rapid developments is pharmaceutical sciences and technology, it became necessary to make further changes in the existing compendium. Addendum 2002 amends as well as adds new drugs and preparations to the Indian pharmacopoeia 1996 with a view to keeping the pharmacopoeia updated to the extent possible. Besides amending the existing monographs and appendices, it contains 19 new monographs including monographs of 12 antiretroviral drugs and 7 formulations of these substances. A new appendix on residual solvents has been incorporated. Some monographs have undergone major amendments. The appendix on high performance liquid chromatography has been replaced with a new version which also includes the ion chromatography. The Addendum 2002 is a companion volume to the Indian pharmacopoeia which is indispensable for all concerned with the quality of drugs.















Friday, February 12, 2010

Dietary supplements 3rd edition

Dietary Supplements 3rd Edition


The use of dietary supplements has continued to increase steadily in recent years with, for example, 40 per cent of UK adults said to be taking such supplements on a regular basis. Although they are widely used, the use of dietary supplements is controversial in relation to their efficacy and safety and much recent research has been published considering these questions. This comprehensive new edition of "Dietary Supplements" has been completed revised and updated to include the latest findings on the most commonly used dietary supplements. This edition contains 82 regularly structured monographs with information on: uses, action, safety (adverse effects, pregnancy, interactions), efficacy, and dosage; full revised and updated with findings from the recent literature on common supplements such as: aloe vera, calcium, creatine, glucosamine, selenium, and vitamin C; includes 10 monographs new to this edition on: methylsulfonylmethane (MSM), nickel, pcynogenol, phytosterols, psyllium, quercetin, resveratrol, silicon, tin and vanadium; considers regulations relating to dietary supplements in UK, Europe and the USA; and useful appendices include a summary of interactions with conventional medicines.








Herbal medicines, 3rd Edition

Herbal Medicines, 3rd Edition



Herbal medicinal products are increasing in popularity in the developed world although there are many concerns about their quality, safety and efficacy. "Herbal Medicines" provides a comprehensive single source of scientifically rigorous, impartial information on over 150 of the most commonly used herbal medicinal products. This third edition has been extensively revised and updated. It aims to answer the questions raised for the healthcare professional by providing scientifically rigorous, impartial information on medical herbs.

Herbal supplements-drug interactions: scientific and regulatory and regulatory perspectives

Herbal Supplements-Drug Interactions: Scientific and Regulatory Perspectives


The international popularity of herbal remedies has recently outpaced quality information on the utilization and dosing of these compounds. This book fills a void in the literature by offering an authoritative overview of the mechanisms of herbal remedies and their impact on standard medications. It offers a practical approach that focuses not only on specific drug interactions, but the mechanisms behind those interactions and their clinical significance. With contributions from leading experts on the subject, this text examines the overall use of herbs, includes sections on individual herbs, and considers pertinent regulatory issues and concerns in industry.

Flavours and fragrances: chemistry, bioprocessing and sustainability

Flavours and Fragrances: Chemistry, Bioprocessing and Sustainability


This book is an introduction to the fascinating world of aroma chemicals, essential oils, fragrances and flavour compositions for the food, cosmetics and pharmaceutical industry.


European pharmacopoeia, 4th edition

European Pharmacopoeia, 4th edition


The European Pharmacopoeia is a single reference work for the quality control of medicines in Europe. Several legal texts make the European Pharmacopoeia mandatory


USP NF 2009 ( UNITED STATES PHARMACOPOEIA 32/ NATIONAL FORMULARY 27)

USP NF 2009 (United States Pharmacopeia 32 / National Formulary 27)


British pharmacopoeia 2009

British Pharmacopoeia 2009


"The British Pharmacopoeia" ("BP") 2009 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy.The "BP" comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. Detailed information and guidance on various aspects of current pharmacopoeial policy and practice are provided in the Supplementary Chapters of the "BP".The "BP" is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition comprises a five-volume boxed set containing the "BP" in four volumes and the "BP" (Veterinary) volume, plus single user access to the "BP" Online, the dedicated BP website. The online format is easy to network, allowing access for a specified number of users or across an entire organisation site.Following registration - using the ID code supplied with the hard copy - customers will be granted a single user licence to access BP on-line and will have the option to receive the CD-ROM, which contains the whole of the current "British Pharmacopoeia".It is effective as of 1 January 2009. It includes: a significant number of new UK monographs; all "European Pharmacopoeia 6th Edition" material up to and including "Supplement 6.2" integrated into the text of "BP 2009"; new and revised monographs for Complementary, Herbal and Homoeopathic medicines with their own section in Volume III; and networking with full technical support from TSO, the publisher of the "BP". The on-line version delivers the complete text of the "British Pharmacopoeia and European Pharmacopoeia" standards to your PC. The new features include an alphabetical index, user-friendly search interface design, and a facility to create a 'My BP' section." British Pharmacopoeia 2009" eBook - "The complete British Pharmacopoeia 2009" is now available exclusively to "BP 2009" purchasers in an innovative new format. The eBook is greatly suited to this large reference text making the information contained within it available to all of those who wish to access it on the move and away from their desks.British Pharmacopoeia 2009 Concurrent Licence (Online) - "The British Pharmacopoeia" is available as a network licence which can be used on a concurrent user basis. It allows a designated number of staff simultaneous access to the online version of the "British Pharmacopoeia 2009". Once set up, your workforce can then start using the BP at their convenience.

Fiedler encyclopedia of excipients: for pharmaceuticals, cosmetics and related areas

      Fiedler Encyclopedia of Excipients: For Pharmaceuticals, Cosmetics and Related Areas


The two-volume encyclopedia offers a detailed description of properties, analyses and characteristic data for more than 17,000 excipients used in the manufacture of pharmaceuticals, cosmetics and related products.

Martindale: the complete drug reference, 36th edition

Martindale: The Complete Drug Reference, 36th Edition


This book provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world.

Molecular biology and biotechnology

3)Molecular Biology and Biotechnology



As a textbook, Molecular Biology and Biotechnology has always been immensely popular. Now in its fourth edition, it has been completely revised and updated to provide a comprehensive overview of the area, and to reflect all the latest developments.

Pharmaceutical Biotechnology













Modern industrial microbiology and biotechnology

Modern Industrial Microbiology and Biotechnology


Business Development in the Biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate take-overs are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects.The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.


download